Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMAI Capital Management
Latest Disclosed Ownership87,280 shares
Latest Disclosed Value $ 30,709,607
MAI Capital Management reports 0.99% increase in ownership of AMGN / Amgen Inc.

On May 15, 2026 - MAI Capital Management filed a 13F-HR form disclosing ownership of 87,280 shares of Amgen Inc. (CH:AMGN) valued at $30,709,607 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 86,424 shares of Amgen Inc.. This represents a change in shares of 0.99% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 87,280 856 0.99 30,710 8.56 0.1733
2026-02-13 2025-12-31 13F AMGEN COM 031162100 86,424 9,133 11.82 28,288 29.69 0.1627
2025-11-10 2025-09-30 13F AMGEN COM 031162100 77,291 6,660 9.43 21,811 10.60 0.1358
2025-08-12 2025-06-30 13F AMGEN COM 031162100 70,631 -767 -1.07 19,721 -11.35 0.1363
2025-05-15 2025-03-31 13F AMGEN COM 031162100 71,398 372 0.52 22,244 20.16 0.1677
2025-02-14 2024-12-31 13F AMGEN COM 031162100 71,026 31,595 80.13 18,512 45.71 0.1372
2024-11-07 2024-09-30 13F Amgen CS 031162100 39,431 -5,862 -12.94 12,705 -10.22 0.1210
2024-08-12 2024-06-30 13F Amgen CS 031162100 45,293 -481 -1.05 14,152 8.74 0.1386
2024-05-08 2024-03-31 13F Amgen CS 031162100 45,774 6,933 17.85 13,014 16.34 0.1348
2024-02-09 2023-12-31 13F Amgen CS 031162100 38,841 19 0.05 11,187 7.22 0.1470
2023-11-14 2023-09-30 13F Amgen CS 031162100 38,822 559 1.46 10,434 22.81 0.1552
2023-08-02 2023-06-30 13F Amgen CS 031162100 38,263 -1,131 -2.87 8,495 -10.79 0.1250
2023-05-10 2023-03-31 13F Amgen CS 031162100 39,394 -1,843 -4.47 9,524 -12.07 0.1500
2023-02-09 2022-12-31 13F Amgen CS 031162100 41,237 -484 -1.16 10,831 15.16 0.1819
2022-11-15 2022-09-30 13F Amgen CS 031162100 41,721 9,496 29.47 9,404 19.95 0.1766
2022-07-19 2022-06-30 13F Amgen CS 031162100 32,225 -1,246 -3.72 7,840 -3.14 0.1497
2022-05-10 2022-03-31 13F Amgen CS 031162100 33,471 -1,461 -4.18 8,094 2.99 0.1360
2022-02-11 2021-12-31 13F Amgen CS 031162100 34,932 -38,571 -52.48 7,859 -49.72 0.1266
2021-11-12 2021-09-30 13F Amgen CS 031162100 73,503 3,153 4.48 15,630 -8.85 0.3009
2021-07-19 2021-06-30 13F Amgen CS 031162100 70,350 28 0.04 17,148 -1.99 0.3404
2021-05-10 2021-03-31 13F Amgen CS 031162100 70,322 -12,562 -15.16 17,497 -8.19 0.3911
2021-02-16 2020-12-31 13F Amgen CS 031162100 82,884 1,688 2.08 19,057 -7.66 0.4765
2020-10-26 2020-09-30 13F Amgen CS 031162100 81,196 -135 -0.17 20,637 7.58 0.5975
2020-07-27 2020-06-30 13F Amgen CS 031162100 81,331 1,920 2.42 19,183 19.16 0.6022
2020-04-16 2020-03-31 13F Amgen CS 031162100 79,411 2,931 3.83 16,099 -12.68 0.6570
2020-02-03 2019-12-31 13F Amgen CS 031162100 76,480 869 1.15 18,437 26.00 0.5975
2019-10-29 2019-09-30 13F Amgen CS 031162100 75,611 -2,413 -3.09 14,632 1.77 0.6521
2019-08-15 2019-06-30 13F Amgen CS 031162100 78,024 76 0.10 14,378 -2.91 0.6497
2019-04-29 2019-03-31 13F Amgen CS 031162100 77,948 1,446 1.89 14,809 -0.56 0.7583
2019-01-30 2018-12-31 13F Amgen CS 031162100 76,502 4,057 5.60 14,893 -0.83 0.8680
2018-10-12 2018-09-30 13F Amgen CS 031162100 72,445 -534 -0.73 15,017 11.48 0.7672
2018-08-16 2018-06-30 13F Amgen CS 031162100 72,979 1,514 2.12 13,471 10.57 0.7266
2018-04-17 2018-03-31 13F Amgen CS 031162100 71,465 735 1.04 12,183 -0.95 0.6917
2018-01-30 2017-12-31 13F Amgen CS 031162100 70,730 -3,193 -4.32 12,300 -10.76 0.6988
2017-10-12 2017-09-30 13F Amgen CS 031162100 73,923 191 0.26 13,783 8.54 0.8368
2017-08-07 2017-06-30 13F Amgen CS 031162100 73,732 694 0.95 12,699 5.98 0.8181
2017-05-11 2017-03-31 13F Amgen CS 031162100 73,038 -2,079 -2.77 11,983 9.10 0.8063
2017-01-31 2016-12-31 13F Amgen CS 031162100 75,117 6,308 9.17 10,983 -4.31 0.7986
2016-10-18 2016-09-30 13F Amgen CS 031162100 68,809 -5,516 -7.42 11,478 1.49 0.8657
2016-07-14 2016-06-30 13F Amgen CS 031162100 74,325 -8,810 -10.60 11,309 -9.27 0.8716
2016-04-08 2016-03-31 13F Amgen CS 031162100 83,135 114 0.14 12,464 -7.52 0.9532
2016-01-27 2015-12-31 13F Amgen CS 031162100 83,021 -2,380 -2.79 13,477 14.09 1.0275
2015-10-28 2015-09-30 13F Amgen CS 031162100 85,401 2,114 2.54 11,813 -7.61 0.8935
2015-07-09 2015-06-30 13F Amgen CS 031162100 83,287 903 1.10 12,786 -2.91 0.8425
2015-04-30 2015-03-31 13F Amgen CS 031162100 82,384 19,360 30.72 13,169 31.18 0.8824
2015-01-20 2014-12-31 13F Amgen CS 031162100 63,024 1,860 3.04 10,039 16.85 0.7040
2014-10-16 2014-09-30 13F/A-1 Amgen CS 031162100 61,164 1,100 1.83 8,591 20.83 0.8277
2014-10-16 2014-09-30 13F Amgen COM 031162100 60,064 7,110
2014-07-28 2014-06-30 13F Amgen COM 031162100 60,064 56,022 1,386.00 7,110 1,324.85 0.6832
2014-04-28 2014-03-31 13F Amgen COM 031162100 4,042 0 0.00 499 8.24 0.0502
2014-02-06 2013-12-31 13F Amgen COM 031162100 4,042 0 0.00 461 1.99 0.0489
2013-10-28 2013-09-30 13F Amgen COM 031162100 4,042 500 14.12 452 29.51 0.0587
2013-08-01 2013-06-30 13F Amgen COM 031162100 3,542 3,542 349 0.0455
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.